Skip to content

D2S Pharma

Active Private limited companyfounded 2014active for 12 yearsBerchemweg 139, 9700 OudenaardeKBO/BCE: BE 0563.446.868

Annual accounts 2025

abbreviated format, filed on 20-02-2026, 20 days late
€129,195
▲ 16.3%
€54,013
▲ 103%
€38,474
▲ 117%
€387,409
▲ 20.4%
72.9%
▲ 0.9 percentage points
5.11
▼ 0.08

Turnover is estimated at about €330,000, probably between €200,000 and €630,000. The abbreviated format does not state turnover.

Balance sheet

balance sheet total €582,318 on 30-06-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

72.9%

Higher than 82% of the 84 companies filing abbreviated accounts in pharmaceuticals (NACE 21) in 2025.

5.11

Higher than 85% of the 84 companies filing abbreviated accounts in pharmaceuticals (NACE 21) in 2025.

6.6%

Higher than 74% of the 84 companies filing abbreviated accounts in pharmaceuticals (NACE 21) in 2025.

D2S Pharma Middle half of the sector 80% of the sector Abbreviated accounts in pharmaceuticals (NACE 21)

Net result: middle half · Equity: middle half · Balance sheet total: bottom quarter · Working capital: middle half · Staff: bottom quarter

Staff

€53,819

Staff costs divided by the average number of full-time equivalents.

employees who joined employees who left

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023202220212020201920182017201621 months
94,31268,56749,33859,967291,750191,18455,71027,537-14,029-59,692
78,77359,64146,22853,445225,459159,94753,52324,447-15,651-69,160
3,3134,9365,43637,57887,0274,61162,9672,200165,70033,163
46,493-2,5599,434-83,429150,96364,947-19,9067,335-73,531-
387,409321,901281,663267,588284,662113,105-24,578-2,422-68,490135
72.9%72.0%66.2%61.0%52.5%28.8%9.5%2.6%2.3%15.5%
5.115.183.793.272.691.400.830.980.511.00
2.622.791.951.621.740.920.440.470.270.72
0.370.390.510.640.902.479.5437.7141.955.43
9.1%4.6%0.7%3.4%54.0%81.2%76.8%14.0%-352.4%-262.8%
6.6%3.3%0.5%2.1%28.4%23.4%7.3%0.4%-8.2%-40.8%
38.2521.9414.3114.13------

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023202220212020201920182017201621 months
Balance sheet: assets
20/58 582,318536,409557,033599,904673,445564,207322,557274,321261,706177,361
21/28 100,573137,559174,558214,575220,646168,043198,224165,259189,76829,888
21 12,54716,87121,19525,51928,00032,30343,77710,69512,9132,863
22/27 80,338113,000145,675179,568187,331132,852151,609151,727174,01725,087
23 63,35591,423122,748153,085183,059131,440148,014145,948165,98115,974
24 2,3374,3042,9444,3514,0419492,9024,8546,8809,113
26 14,64617,27319,98322,1322314626939241,156-
28 7,6887,6887,6889,4885,3152,8882,8382,8382,8381,938
29/58 481,746398,851382,474385,328452,799396,164124,333109,06271,938147,473
3 234,923183,978185,417194,601159,550134,39259,23556,26133,97941,731
30/36 234,923183,978185,417194,601159,550134,39259,23556,26133,97941,731
40/41 48,66667,00245,87550,14760,263191,37260,05927,76321,76716,057
40 48,66666,05342,54344,00055,748178,97460,03027,75120,75810,474
41 -9493,3326,1474,51512,39729121,0105,583
54/58 188,504142,011144,570135,136218,56567,6012,65422,56015,22588,756
490/1 9,6525,8606,6135,44514,4222,7992,3842,479966929
Balance sheet: equity and liabilities
10/49 582,318536,409557,033599,904673,445564,207322,557274,321261,706177,361
10/15 424,697386,223368,518365,944353,632162,59630,6077,0876,09327,565
10/11 100,000100,000100,000100,000100,000-100,000100,000100,000100,000
100 ------100,000100,000100,000100,000
11 -----100,000----
1100/10 -----100,000----
14 324,697286,223268,518265,944253,63262,596-69,393-92,913-93,907-72,435
17/49 157,621150,186188,515233,960319,814401,611291,949267,235255,613149,796
17 60,00069,50383,659112,483146,118116,902141,179153,643113,357-
170/4 60,00069,50383,659112,483146,118116,902141,179153,643113,357-
42/48 94,33776,950100,811117,740168,137283,059148,910111,484140,428147,338
42 9,50314,15628,82433,63636,20724,27724,22219,71419,714-
43 3---------
430/8 3---------
44 55,93628,04830,54234,63265,061102,13222,65710,86010,38216,048
440/4 55,93628,04830,54234,63265,061102,13222,65710,86010,38216,048
45 9,15410,3004,0724,6133,58834,2031,8421,058615925
450/3 5,2365,9177801,312-29,752904110--
454/9 3,9194,3833,2933,3013,5884,451937949615925
47/48 19,74024,44537,37444,86063,280122,447100,19079,852109,716130,365
492/3 3,2853,7334,0443,7375,5581,6501,8602,1081,8282,458
Income statement
9900 129,195111,07573,83485,449330,648215,27866,63236,434-5,662-55,161
62 26,90932,07523,74524,06728,28916,5219,8477,8546,9881,915
630 40,29941,93643,65341,13334,42327,95930,00223,4545,8203,275
631/4 ----4,382-----
640/8 7,97410,4337521,4166,2287,5731,0751,0431,3792,616
9901 54,01326,6315,68518,834257,327163,22525,7074,084-19,849-62,967
75/76B 1,6671,5521,8211,3374499136112
75 1,6671,5521,8211,3374499136112
65/66B 2,4663,1253,4484,2459,1231,4942,1883,1261,6249,480
65 2,4663,1253,4484,2459,1231,4942,1883,1261,6249,480
9903 53,21425,0584,05815,926248,653161,74023,521993-21,472-72,435
67/77 14,7407,3531,4833,61557,61729,752----
9904 38,47417,7052,57512,312191,036131,98823,521993-21,472-72,435
9905 38,47417,7052,57512,312191,036131,98823,521993-21,472-72,435
Appropriation of the result
9906 324,697286,223268,518265,944253,63262,596-69,393-92,913-93,907-72,435
14P 286,223268,518265,944253,632------
Social balance sheet
9087 0.50.60.50.60.50.40.40.30.3-
Hours worked1013 1,2001,4281,0221,1881,504856503375306-
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The full notes are in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 20-02-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank

The accounts were filed on 20-02-2026. The deadline was 31-01-2026, 7 months after the close on 30-06-2025 (article 3:10 of the Companies and Associations Code). Source: NBB, 2026-00042958.

Financial year Type Filed Reference Document
30-06-2025 abbreviated format 20-02-2026 2026-00042958 PDF
30-06-2024 abbreviated format 07-01-2025 2025-00000493 PDF
30-06-2023 abbreviated format 09-02-2024 2024-00030283 PDF
30-06-2022 abbreviated format 25-01-2023 2023-00006543 PDF
30-06-2021 abbreviated format 28-01-2022 2022-03100337 PDF
30-06-2020 abbreviated format 27-01-2021 2021-02600274 PDF
30-06-2019 abbreviated format 20-12-2019 2019-76800380 PDF
30-06-2018 abbreviated format 23-01-2019 2019-02000396 PDF
30-06-2017 micro format 10-01-2018 2018-01000385 PDF
30-06-2016 abbreviated format 16-01-2017 2017-01300301 PDF

Subsidies and aid

Flemish government 2023, 1 entry, €126 awarded, €126 paid

Social balance sheet

Item30-06-202530-06-202430-06-202330-06-2022
Employees at the balance-sheet date2222
part-time2222
in full-time equivalents0.50.50.50.5
0.50.60.50.6
On a permanent contract2222
Joined-121
Left-121

Source: social balance sheet in the 2022 to 2025 annual accounts

Investments

fixed assets acquired
Item30-06-202530-06-202430-06-202330-06-2022
Tangible fixed assets€3,313€4,936€5,436€29,270
Intangible fixed assets---€1,620
Financial fixed assets---€6,688
€40,299€41,936€43,653€41,133

Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)

Insights on D2S Pharma

The operating result for 2025 is 103% higher than in 2024 and the highest since 2021. It is the second rise in a row, after the fall in 2023.

Debt's share of the balance-sheet total falls from 28.0% to 27.1%. Equity and debt are higher.

Next steps